SEC Form D filing

Atlantic Labs 4 GmbH & Co. KG Form D: venture fund offering, size indefinite (Oct 2, 2026)

Atlantic Labs 4 GmbH & Co. KG filed an amended Form D (D/A) with the SEC on October 2, 2026 for an offering of indefinite size, as a venture capital fund based in Berlin. $565K had been sold to 2 investors at filing. Related persons named on the filing: Christophe F. Maire and Marc-Olivier Lucke. The fund manager is Atlantic Labs.

Updated · source: SEC EDGAR · view the filing

Filing facts

Issuer (as filed)
Atlantic Labs 4 GmbH & Co. KG
SEC CIK
2089549
Latest filing
Form type
D/A (amendment to an earlier offering)
Total offering amount
Indefinite
Address on the filing
Berlin
Fund type on the filing
Venture Capital Fund
Organized
Germany, 2025
Exemptions claimed
Rule 506(b); Investment Company Act 3(c)(7), qualified purchasers only
Date of first sale
Sep 1, 2025
Amount sold at filing
$565K
Investors at filing
2
Fund manager
Atlantic Labs →

People named on the filing

  • Christophe F. MaireExecutive Officer · Promoter · Christophe Maire is a Managing Director of Atlantic Labs Manager GmbH, the Manager of the Issuer.
  • Marc-Olivier LuckeExecutive Officer · Promoter · Marc-Olivier is a Managing Director of Atlantic Labs Manager GmbH, the Manager of the Issuer.

Related persons are the executive officers, directors and promoters the issuer lists in Item 3 of Form D. Addresses on the filing are not reproduced here.

Related

Frequently asked questions

When did Atlantic Labs 4 GmbH & Co. KG file its Form D?

Atlantic Labs 4 GmbH & Co. KG (SEC CIK 2089549) filed a Form D on October 2, 2026. The filing is public on SEC EDGAR.

Who runs Atlantic Labs 4 GmbH & Co. KG?

The Form D names Christophe F. Maire (Executive Officer, Promoter, Christophe Maire is a Managing Director of Atlantic Labs Manager GmbH, the Manager of the Issuer.) and Marc-Olivier Lucke (Executive Officer, Promoter, Marc-Olivier is a Managing Director of Atlantic Labs Manager GmbH, the Manager of the Issuer.) as related persons. Related persons are the executive officers, directors and promoters of the issuer or its general partner.

Which SEC exemption does Atlantic Labs 4 GmbH & Co. KG rely on?

Rule 506(b) and Investment Company Act 3(c)(7), qualified purchasers only, as claimed on the filing.

Sources

Updated